AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17244293 — intervention group
Group type: COMPARATOR
Intervention: Medicaid services as usual (control group)
Number of subjects: 0
Study 17244293 — intervention group
Group type: EXPERIMENTAL
Intervention: Cash and Counseling (treatment group) among elderly in Florida
Number of subjects: 0
Study 15717934 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 36
Study 15717934 — intervention group
Group type: COMPARATOR
Intervention: Vestibular Rehabilitation (VR)
Number of subjects: 36
Study 11928802 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast conservation therapy as a primary therapeutic procedure
Number of subjects: 0
Study 11928802 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 0
Study 10515471 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine treatment
Number of subjects: 127
Study 10515471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study 7726705 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 617
Study 7726705 — intervention group
Group type: COMPARATOR
Intervention: Didanosine (500 mg/d)
Number of subjects: 617
Study 7726705 — intervention group
Group type: COMPARATOR
Intervention: Didanosine (750 mg/d)
Number of subjects: 617
Study 7726705 — intervention group
Group type: COMPARATOR
Intervention: Zidovudine, Didanosine (500 mg/d), Didanosine (750 mg/d)
Number of subjects: 617
Study 2304988 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone-gel implants
Number of subjects: 65
Study 2304988 — intervention group
Group type: COMPARATOR
Intervention: Saline-filled implants
Number of subjects: 65
Study 2304988 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall satisfaction
Number of subjects: 65
Study 6798924 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosoxacin 100 mg
Number of subjects: 126
Study 6798924 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosoxacin 200 mg, 300 mg, or 400 mg
Number of subjects: 126
Study 6798924 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosoxacin
Number of subjects: 126
Study 29284097 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% Lase Peroxide Sensy (LPS) + HL
Number of subjects: 20
Study 29284097 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide (HP) + HL
Number of subjects: 20
Study 29284097 — intervention group
Group type: COMPARATOR
Intervention: 35% LPS
Number of subjects: 20
Study 29284097 — intervention group
Group type: COMPARATOR
Intervention: 35% HP
Number of subjects: 20
Study 29284097 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% LPS + HL
Number of subjects: 20
Study 29284097 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% HP + HL
Number of subjects: 20
Study 29284097 — intervention group
Group type: COMPARATOR
Intervention: 35% Whiteness HP (WHP)
Number of subjects: 20
Study 27424687 — intervention group
Group type: EXPERIMENTAL
Intervention: KAA (α-keto analogs of essential amino acids)
Number of subjects: 96
Study 27424687 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhubarb
Number of subjects: 96
Study 27424687 — intervention group
Group type: COMPARATOR
Intervention: Control (Conservative management + placebo)
Number of subjects: 96
Study 25004196 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga (1-hour class weekly for 10 weeks)
Number of subjects: 64
Study 25004196 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 64
Study 25004196 — intervention group
Group type: COMPARATOR
Intervention: Control (supportive women's health education, 1-hour class weekly for 10 weeks)
Number of subjects: 64
Study 25004196 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 64
Study 21733292 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug cues in abstaining smokers
Number of subjects: 72
Study 21733292 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette cues in abstaining smokers
Number of subjects: 72
Study 21733292 — intervention group
Group type: COMPARATOR
Intervention: Neutral cues in abstaining smokers
Number of subjects: 72
Study 20691131 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus PRSF-L477 (1 × 10¹¹ cfu daily for 3 weeks)
Number of subjects: 34
Study 20691131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 20691131 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus PRSF-L477
Number of subjects: 34
Study 19033001 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 672
Study 19033001 — intervention group
Group type: COMPARATOR
Intervention: Glipizide
Number of subjects: 672
Study 15717257 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine
Number of subjects: 168
Study 15717257 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study 12832316 — intervention group
Group type: EXPERIMENTAL
Intervention: Nateglinide (120 mg)
Number of subjects: 1170
Study 12832316 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1170
Study 10944134 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose neuraxis irradiation (36 Gy in 20 fractions)
Number of subjects: 126
Study 10944134 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-dose neuraxis irradiation (23.4 Gy in 13 fractions)
Number of subjects: 126
Study 8818064 — intervention group
Group type: EXPERIMENTAL
Intervention: CATCH Eat Smart intervention
Number of subjects: 56
Study 8818064 — intervention group
Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 56
Study 1408298 — intervention group
Group type: EXPERIMENTAL
Intervention: Facet joint injection
Number of subjects: 86
Study 1408298 — intervention group
Group type: COMPARATOR
Intervention: Facet nerve block
Number of subjects: 86
Study 3869441 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-acting glucagon
Number of subjects: 0
Study 3869441 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot-glucagon
Number of subjects: 0
Study 3869441 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3869441 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study 3730766 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexabrix 320
Number of subjects: 45
Study 3730766 — intervention group
Group type: EXPERIMENTAL
Intervention: iohexol 300
Number of subjects: 45
Study 3730766 — intervention group
Group type: EXPERIMENTAL
Intervention: iohexol 240
Number of subjects: 45
Study 28358751 — intervention group
Group type: EXPERIMENTAL
Intervention: Angled trocar insertion
Number of subjects: 30
Study 28358751 — intervention group
Group type: COMPARATOR
Intervention: Straight trocar insertion
Number of subjects: 30
Study 27500336 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal corticosteroids
Number of subjects: 850
Study 24935579 — intervention group
Group type: EXPERIMENTAL
Intervention: EANI combined with hydrochloride palonosetron
Number of subjects: 120
Study 24935579 — intervention group
Group type: COMPARATOR
Intervention: Hydrochloride palonosetron alone
Number of subjects: 120
Study 22489444 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care plus study map
Number of subjects: 30
Study 22489444 — intervention group
Group type: COMPARATOR
Intervention: Standard care group (verbal description with consent documents)
Number of subjects: 30
Study 20535016 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 0
Study 20535016 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 0
Study 20535016 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine and Placebo
Number of subjects: 0
Study 18783503 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (900 mg/day)
Number of subjects: 40
Study 18783503 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 16170642 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (T)
Number of subjects: 1000
Study 16170642 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine (I)
Number of subjects: 1000
Study 16170642 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine + Iodine (TI)
Number of subjects: 1000
Study 16170642 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 1000
Study 12914812 — intervention group
Group type: EXPERIMENTAL
Intervention: Suppressing anxious thoughts
Number of subjects: 32
Study 11192136 — intervention group
Group type: EXPERIMENTAL
Intervention: Zaleplon 10 mg
Number of subjects: 10
Study 11192136 — intervention group
Group type: EXPERIMENTAL
Intervention: Zaleplon 20 mg
Number of subjects: 10
Study 11192136 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 10
Study 11192136 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 20 mg
Number of subjects: 10
Study 11192136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 8669674 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 375
Study 8669674 — intervention group
Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 375
Study 1372855 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon gamma-1b (IFN gamma-1b)
Number of subjects: 0
Study 3874009 — intervention group
Group type: EXPERIMENTAL
Intervention: 325 mg tid aspirin (ASA) plus 75 mg tid dipyridamole (DP)
Number of subjects: 147
Study 3874009 — intervention group
Group type: EXPERIMENTAL
Intervention: 325 mg tid aspirin (ASA)
Number of subjects: 147
Study 3874009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 3874009 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-inhibiting therapy (ASA + DP)
Number of subjects: 147
Study 31900097 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD group
Number of subjects: 107
Study 31900097 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 107
Study 31390595 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal fat oxidation
Number of subjects: 74
Study 31390595 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal fat oxidation during exercise (MFO)
Number of subjects: 74
Study 31390595 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal metabolic rate (BMR)
Number of subjects: 74
Study 29543631 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous amisulpride (5 mg)
Number of subjects: 1147
Study 29543631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1147
Study 26686527 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea polyphenol infused with milk (GTPM)
Number of subjects: 44
Study 26686527 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 25274174 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive sex education program with family involvement
Number of subjects: 2453
Study 25274174 — intervention group
Group type: EXPERIMENTAL
Intervention: Family activities during the first year of the program
Number of subjects: 2453
Study 23715188 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisped® (5 mg montelukast chewable tablets)
Number of subjects: 18
Study 23715188 — intervention group
Group type: COMPARATOR
Intervention: Singulair® (5 mg montelukast chewable tablets)
Number of subjects: 18
Study 20131276 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab plus MTX
Number of subjects: 0
Study 20131276 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus MTX
Number of subjects: 0
Study 20131276 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab monotherapy
Number of subjects: 0
Study 20131276 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab 4 mg/kg plus MTX
Number of subjects: 0
Study 20131276 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab with or without MTX
Number of subjects: 0
Study 17267204 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate plus etoposide and ifosfamide
Number of subjects: 234
Study 17267204 — intervention group
Group type: COMPARATOR
Intervention: High-dose methotrexate plus doxorubicin
Number of subjects: 234
Study 16217785 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturation recovery SSFP technique
Number of subjects: 16
Study 12377864 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 4% amethocaine gel applied for 30 min prior to the radial arterial puncture
Number of subjects: 0
Study 12377864 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 0
Study 12377864 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 4% amethocaine gel
Number of subjects: 0
Study 10768802 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based intervention to increase fruit and vegetable intake
Number of subjects: 0
Study 10768802 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of informational materials
Number of subjects: 0
Study 10768802 — intervention group
Group type: EXPERIMENTAL
Intervention: Work sites with medium average baseline intake
Number of subjects: 0
Study 8646678 — intervention group
Group type: EXPERIMENTAL
Intervention: Excision margin of 2 cm
Number of subjects: 769
Study 8646678 — intervention group
Group type: COMPARATOR
Intervention: Excision margin of 5 cm
Number of subjects: 769
Study 1514483 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual and prolonged balloon inflation with a perfusion balloon catheter (inflated to 6 atm over 3 minutes, median inflation time of 15 minutes)
Number of subjects: 140
Study 1514483 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual and prolonged balloon inflation with a perfusion balloon catheter
Number of subjects: 140
Study 4067888 — intervention group
Group type: EXPERIMENTAL
Intervention: Speech therapy for 24 weeks starting at 10 weeks post-stroke
Number of subjects: 0
Study 30714684 — intervention group
Group type: EXPERIMENTAL
Intervention: EMDR + Standard Care (SC)
Number of subjects: 29
Study 30714684 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 29
Study 28479412 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-focused grief therapy (not specified dosage or duration)
Number of subjects: 620
Study 28479412 — intervention group
Group type: COMPARATOR
Intervention: Low-communicating families
Number of subjects: 620
Study 28479412 — intervention group
Group type: COMPARATOR
Intervention: Uninvolved families
Number of subjects: 620
Study 28479412 — intervention group
Group type: COMPARATOR
Intervention: Conflictual families
Number of subjects: 620
Study 25230595 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic radiotherapy (30 Gy in ten fractions)
Number of subjects: 498
Study 25230595 — intervention group
Group type: COMPARATOR
Intervention: Control (no thoracic radiotherapy)
Number of subjects: 498
Study 25230595 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic radiotherapy
Number of subjects: 498
Study 25230595 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 498
Study 22775799 — intervention group
Group type: EXPERIMENTAL
Intervention: Static magnetic field exposure (1.5 T, 3 T, 7 T)
Number of subjects: 41
Study 22775799 — intervention group
Group type: COMPARATOR
Intervention: Mock scanner (0 T)
Number of subjects: 41
Study 21455041 — intervention group
Group type: EXPERIMENTAL
Intervention: Left lateral position
Number of subjects: 512
Study 21455041 — intervention group
Group type: COMPARATOR
Intervention: Right lateral position
Number of subjects: 512
Study 21455041 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 512
Study 18426714 — intervention group
Group type: EXPERIMENTAL
Intervention: Aboral pouch reconstruction
Number of subjects: 0
Study 18426714 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal passage preserving version
Number of subjects: 0
Study 18426714 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal passage preserving reconstruction
Number of subjects: 0
Study 18426714 — intervention group
Group type: COMPARATOR
Intervention: Duodenal exclusion
Number of subjects: 0
Study 16427320 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitch memory training (1 hour/day for 5 days)
Number of subjects: 14
Study 16427320 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 14
Study 16427320 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of SL and WL groups post-training
Number of subjects: 14
Study 14520654 — intervention group
Group type: EXPERIMENTAL
Intervention: Substantial acute recovery (improvement of ≥75% on NIHSS)
Number of subjects: 1184
Study 14520654 — intervention group
Group type: COMPARATOR
Intervention: No substantial acute recovery
Number of subjects: 1184
Study 10636259 — intervention group
Group type: EXPERIMENTAL
Intervention: BG9719
Number of subjects: 12
Study 10636259 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide
Number of subjects: 12
Study 10636259 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 9268255 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive physician education over a 12-month period including case consultations, didactics, academic detailing, and role-play.
Number of subjects: 0
Study 9268255 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted program of collaborative care during the training period.
Number of subjects: 0
Study 9268255 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 8328656 — intervention group
Group type: EXPERIMENTAL
Intervention: Astemizole (10 mg)
Number of subjects: 7
Study 8328656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 3472139 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral scopolamine hydrobromide solution (ScHBr), 0.02 mg/kg total body weight, rinsed in the mouth for 5 minutes before swallowing
Number of subjects: 10
Study 3472139 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral scopolamine hydrobromide solution (ScHBr) during clinical dental examination procedures
Number of subjects: 10
Study 3472139 — intervention group
Group type: COMPARATOR
Intervention: Placebo during clinical dental examination procedures
Number of subjects: 10
Study 3472139 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral scopolamine hydrobromide solution (ScHBr)
Number of subjects: 10
Study 28718320 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 37.5 mg
Number of subjects: 14
Study 28718320 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 28672854 — intervention group
Group type: EXPERIMENTAL
Intervention: Road safety education materials, two lectures on road safety, and a series of health education activities delivered over one year.
Number of subjects: 1312
Study 28672854 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 1312
Study 25639989 — intervention group
Group type: EXPERIMENTAL
Intervention: Houvast intervention (strengths-based intervention)
Number of subjects: 46
Study 24002499 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiviral treatment (nucleotide/nucleoside analogs: Lamivudine, adefovir dipivoxil, or entecavir)
Number of subjects: 780
Study 24002499 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiviral treatment
Number of subjects: 780
Study 24002499 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antiviral treatment)
Number of subjects: 780
Study 21917146 — intervention group
Group type: EXPERIMENTAL
Intervention: Early continuous lumbar CSF-drainage and standard neurointensive care
Number of subjects: 0
Study 21917146 — intervention group
Group type: COMPARATOR
Intervention: Standard neurointensive care only
Number of subjects: 0
Study 18487572 — intervention group
Group type: EXPERIMENTAL
Intervention: High pain interference scores (>= 17)
Number of subjects: 599
Study 18487572 — intervention group
Group type: COMPARATOR
Intervention: Low pain interference scores (< 17)
Number of subjects: 599
Study 17045093 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic spinal manipulation
Number of subjects: 28
Study 17045093 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 28
Study 12749443 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2
Number of subjects: 74
Study 12749443 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 74
Study 11079638 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group 1
Number of subjects: 106
Study 11079638 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group 2
Number of subjects: 106
Study 11079638 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 106
Study 8956928 — intervention group
Group type: COMPARATOR
Intervention: Temporal lobectomy in patients with unilateral mesial temporal lobe epilepsy (UMTLE) secondary to CNS infection
Number of subjects: 56
Study 8054726 — intervention group
Group type: EXPERIMENTAL
Intervention: Autotransfusion after CABG (n = 42)
Number of subjects: 75
Study 8054726 — intervention group
Group type: COMPARATOR
Intervention: Control group with standard chest drainage (n = 33)
Number of subjects: 75
Study 2493799 — intervention group
Group type: EXPERIMENTAL
Intervention: Magill anaesthetic breathing system
Number of subjects: 12
Study 2493799 — intervention group
Group type: EXPERIMENTAL
Intervention: Lack anaesthetic breathing system
Number of subjects: 12
Study 2493799 — intervention group
Group type: COMPARATOR
Intervention: Both systems at lower fresh gas flow rate
Number of subjects: 12
Study 2493799 — intervention group
Group type: COMPARATOR
Intervention: Both systems at higher fresh gas flow rate
Number of subjects: 12
Study 30983087 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel (20 mg loading/3.75 mg maintenance)
Number of subjects: 78
Study 30983087 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (300 mg loading/75 mg maintenance)
Number of subjects: 78
Study 30396227 — intervention group
Group type: EXPERIMENTAL
Intervention: RAM cannula
Number of subjects: 12
Study 30396227 — intervention group
Group type: COMPARATOR
Intervention: Hudson prongs
Number of subjects: 12
Study 28854542 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative delirium (POD) patients
Number of subjects: 184
Study 28854542 — intervention group
Group type: COMPARATOR
Intervention: Non-POD patients
Number of subjects: 184
Study 28854542 — intervention group
Group type: EXPERIMENTAL
Intervention: POD patients
Number of subjects: 184
Study 25740805 — intervention group
Group type: COMPARATOR
Intervention: Topical 5% natamycin
Number of subjects: 118
Study 25740805 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 1% voriconazole
Number of subjects: 118